^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.DBRW_DATA           
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      AVISITN         4    1 4 8 12                      
      trtn            3    1 2 3                         
      SSNRISN         2    1 2                           
      SEXN            2    1 2                           
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      wk12            2    0 1                           


                          Dimensions

              Covariance Parameters            10
              Columns in X                     39
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               4


                    Number of Observations

          Number of Observations Read             129
          Number of Observations Used             129
          Number of Observations Not Used           0
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       303.01592152                
          1              2       255.25396217      0.03634955
          2              1       254.26673198      0.00523258
          3              1       254.13745367      0.00017168
          4              1       254.13353281      0.00000023
          5              1       254.13352763      0.00000000


                   Convergence criteria met.                    


                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.6391
                UN(2,1)     id           0.2815
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(2,2)     id           0.5067
                UN(3,1)     id           0.2859
                UN(3,2)     id           0.4665
                UN(3,3)     id           0.8976
                UN(4,1)     id           0.4035
                UN(4,2)     id           0.2448
                UN(4,3)     id           0.4822
                UN(4,4)     id           0.6380


                        Fit Statistics

             -2 Res Log Likelihood           254.1
             AIC (Smaller is Better)         274.1
             AICC (Smaller is Better)        276.3
             BIC (Smaller is Better)         290.8
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   9         48.88          <.0001


                 Type 3 Tests of Fixed Effects
 
                         Num     Den
      Effect              DF      DF    F Value    Pr > F

      BASE                 1    31.3      29.43    <.0001
      trtn                 2    25.9       0.99    0.3857
      wk12                 1    18.8       2.54    0.1277
      SSNRISN              1    27.8       2.08    0.1607
      BASE*wk12            1    18.8       0.75    0.3980
      trtn*SEXN            2      26       2.18    0.1328
      trtn*wk12            2    18.3       0.17    0.8469
      SEXN*wk12            1    18.2       0.05    0.8291
      trtn*SEXN*wk12       2    18.1       1.18    0.3306
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                    Sex              Standard
 Effect      trtn   (N)   Estimate      Error     DF   t Value

 trtn*SEXN   1      1      -0.5877     0.5029   24.5     -1.17
 trtn*SEXN   1      2      -0.6392     0.2777   27.9     -2.30
 trtn*SEXN   2      1      -0.8829     0.3190   29.6     -2.77
 trtn*SEXN   2      2      -0.4279     0.2530   27.5     -1.69
 trtn*SEXN   3      1       0.5901     0.7302   24.9      0.81
 trtn*SEXN   3      2      -0.7563     0.2372   29.5     -3.19

                      Least Squares Means
 
                   Sex
Effect      trtn   (N)   Pr > |t|    Alpha      Lower      Upper

trtn*SEXN   1      1       0.2538     0.05    -1.6246     0.4492
trtn*SEXN   1      2       0.0290     0.05    -1.2082   -0.07026
trtn*SEXN   2      1       0.0096     0.05    -1.5349    -0.2310
trtn*SEXN   2      2       0.1021     0.05    -0.9466    0.09080
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                   Sex
Effect      trtn   (N)   Pr > |t|    Alpha      Lower      Upper

trtn*SEXN   3      1       0.4267     0.05    -0.9140     2.0941
trtn*SEXN   3      2       0.0034     0.05    -1.2412    -0.2714
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.DBRW_DATA           
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class       Levels    Values

      id              23    10631001 10631002 10631003    
                            11601002 11601006 11601007    
                            13031001 13581001 13581010    
                            13581014 13991002 13991004    
                            13991007 13991009 16591001    
                            17601005 17601007 17601014    
                            17661004 19731002 19731006    
                            19831001 19901003             
      AVISITN          4    1 4 8 12                      
      SSNRISN1         2    0 1                           


                          Dimensions

              Covariance Parameters            10
              Columns in X                     12
              Columns in Z                      0
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                          Dimensions

              Subjects                         23
              Max Obs per Subject               4


                    Number of Observations

          Number of Observations Read              76
          Number of Observations Used              76
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       183.61823782                
          1              4       151.11406858      0.02269898
          2              1       150.69001072      0.00320761
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          3              1       150.63451364      0.00011751
          4              1       150.63263149      0.00000022
          5              1       150.63262804      0.00000000


                   Convergence criteria met.                    


                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.7784
                UN(2,1)     id           0.3039
                UN(2,2)     id           0.5586
                UN(3,1)     id           0.3817
                UN(3,2)     id           0.5816
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(3,3)     id           1.1042
                UN(4,1)     id           0.5630
                UN(4,2)     id           0.2578
                UN(4,3)     id           0.5075
                UN(4,4)     id           0.6675


                        Fit Statistics

             -2 Res Log Likelihood           150.6
             AIC (Smaller is Better)         170.6
             AICC (Smaller is Better)        174.7
             BIC (Smaller is Better)         182.0
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   9         32.99          0.0001


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
     Effect                DF      DF    F Value    Pr > F

     BASE                   1    17.9      11.59    0.0032
     trtn1                  1    16.1       0.42    0.5280
     wk12                   1    11.9       3.31    0.0940
     SSNRISN1               1    15.8       1.93    0.1835
     SEXN1                  1    15.8       3.65    0.0744
     BASE*wk12              1    11.9       0.81    0.3847
     trtn1*SEXN1            1    15.6       1.21    0.2884
     trtn1*wk12             1    11.8       5.54    0.0367
     wk12*SEXN1             1    11.5       0.85    0.3756
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
     Effect                DF      DF    F Value    Pr > F

     trtn1*wk12*SEXN1       1    11.3       2.89    0.1163


                           Estimates
 
                              Standard
Label               Estimate     Error    DF  t Value  Pr > |t|

1 ACT-PBO  Week 4    -1.4519    1.0240  15.4    -1.42    0.1761
2 ACT-PBO  Week 4    -0.2417    0.3746  16.1    -0.65    0.5280
1 ACT-PBO  Week 12   -2.0833    1.0717  12.8    -1.94    0.0743
2 ACT-PBO  Week 12    0.5515    0.4252  14.2     1.30    0.2152

 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Estimates
 
       Label                Alpha       Lower       Upper

       1 ACT-PBO  Week 4     0.05     -3.6293      0.7254
       2 ACT-PBO  Week 4     0.05     -1.0354      0.5521
       1 ACT-PBO  Week 12    0.05     -4.4026      0.2361
       2 ACT-PBO  Week 12    0.05     -0.3591      1.4621


                           Contrasts
 
                                           Num    Den
 Label                                      DF     DF   F Value

 Treatment*Week 4*Subgroup Interaction       1   15.6      1.21
 Treatment*Week 12*Subgroup Interaction      1   12.5      5.39

 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Contrasts
 
        Label                                    Pr > F

        Treatment*Week 4*Subgroup Interaction    0.2884
        Treatment*Week 12*Subgroup Interaction   0.0379
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.DBRW_DATA           
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class       Levels    Values

      id              30    10631001 10631003 11601002    
                            11601006 13031001 13031004    
                            13581001 13581010 13581014    
                            13991001 13991010 16591003    
                            16591006 17601002 17601003    
                            17601007 17601012 17601025    
                            17661002 17661004 17661006    
                            19691001 19731001 19731002    
                            19731004 19731006 19831001    
                            19831005 19831008 19901003    
      AVISITN          4    1 4 8 12                      
      SSNRISN1         2    0 1                           


 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                          Dimensions

              Covariance Parameters            10
              Columns in X                     12
              Columns in Z                      0
              Subjects                         30
              Max Obs per Subject               4


                    Number of Observations

          Number of Observations Read              96
          Number of Observations Used              96
          Number of Observations Not Used           0


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       232.13824974                
          1              2       198.83950905      0.12501746
          2              1       195.44582539      0.05201515
          3              1       194.18455275      0.01337166
          4              1       193.88865997      0.00132158
          5              1       193.86202483      0.00001759
          6              1       193.86169067      0.00000000


                   Convergence criteria met.                    


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.6466
                UN(2,1)     id           0.3068
                UN(2,2)     id           0.5173
                UN(3,1)     id           0.3775
                UN(3,2)     id           0.4811
                UN(3,3)     id           0.9840
                UN(4,1)     id           0.4338
                UN(4,2)     id           0.3160
                UN(4,3)     id           0.6747
                UN(4,4)     id           0.8114


                        Fit Statistics

             -2 Res Log Likelihood           193.9
             AIC (Smaller is Better)         213.9
             AICC (Smaller is Better)        216.8
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                        Fit Statistics

             BIC (Smaller is Better)         227.9


                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   9         38.28          <.0001


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
     Effect                DF      DF    F Value    Pr > F

     BASE                   1    23.2      27.84    <.0001
     trtn2                  1    22.5       0.36    0.5545
     wk12                   1      13       3.70    0.0766
     SSNRISN1               1    20.9       1.14    0.2969
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
     Effect                DF      DF    F Value    Pr > F

     SEXN1                  1    20.8       1.90    0.1824
     BASE*wk12              1    13.1       1.39    0.2586
     trtn2*SEXN1            1    21.1       3.28    0.0843
     trtn2*wk12             1    13.6       0.51    0.4873
     wk12*SEXN1             1    12.5       0.03    0.8717
     trtn2*wk12*SEXN1       1    12.7       0.02    0.8846


                           Estimates
 
                               Standard
Label                Estimate     Error    DF  t Value  Pr > |t|

1 ACT-PBO    Week 4   -1.5049    0.8526  20.6    -1.77    0.0924
2 ACT-PBO  Week 4      0.1995    0.3326  22.5     0.60    0.5545
1 ACT-PBO  Week 12    -1.1295    1.0895  16.6    -1.04    0.3148
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Estimates
 
                               Standard
Label                Estimate     Error    DF  t Value  Pr > |t|

2 ACT-PBO  Week 12     0.4363    0.4236  17.2     1.03    0.3173

                           Estimates
 
      Label                 Alpha       Lower       Upper

      1 ACT-PBO    Week 4    0.05     -3.2800      0.2702
      2 ACT-PBO  Week 4      0.05     -0.4893      0.8883
      1 ACT-PBO  Week 12     0.05     -3.4324      1.1735
      2 ACT-PBO  Week 12     0.05     -0.4568      1.3294


 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Contrasts
 
                                           Num    Den
 Label                                      DF     DF   F Value

 Treatment*Week 4*Subgroup Interaction       1   21.1      3.28
 Treatment*Week 12*Subgroup Interaction      1   16.6      1.69

                           Contrasts
 
        Label                                    Pr > F

        Treatment*Week 4*Subgroup Interaction    0.0843
        Treatment*Week 12*Subgroup Interaction   0.2107
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
